Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study

NCT05963646 is registered in ClinicalTrials.gov with Institute of Molecular and Clinical Ophthalmology Basel as lead sponsor.

NCT NCT05963646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05963646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study
Lead sponsor
Institute of Molecular and Clinical Ophthalmology Basel
Phase
Observational
Overall status
Completed
Start date
March 16, 2021
Completion date
December 31, 2023
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, geographic atrophy, visual field defect, central scotoma of both eyes